Evidence map›Paper›PMID 31701124›Full record

ArticleNucleic acids research2020

ILF3 contributes to the establishment of the antiviral type I interferon program.

Samir F Watson, Nicolas Bellora, Sara Macias

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Samir F WatsonInstitute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.
Nicolas BelloraIPATEC, CONICET, Bariloche, Argentina.
Sara MaciasInstitute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.
University of Edinburgh · GBConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

Wellcome TrustWellcome Trust 107665/Z/15/Z
6 · The paper itself

Abstract

Upon detection of viral infections, cells activate the expression of type I interferons (IFNs) and pro-inflammatory cytokines to control viral dissemination. As part of their antiviral response, cells also trigger the translational shutoff response which prevents translation of viral mRNAs and cellular mRNAs in a non-selective manner. Intriguingly, mRNAs encoding for antiviral factors bypass this translational shutoff, suggesting the presence of additional regulatory mechanisms enabling expression of the self-defence genes. Here, we identified the dsRNA binding protein ILF3 as an essential host factor required for efficient translation of the central antiviral cytokine, IFNB1, and a subset of interferon-stimulated genes. By combining polysome profiling and next-generation sequencing, ILF3 was also found to be necessary to establish the dsRNA-induced transcriptional and translational programs. We propose a central role for the host factor ILF3 in enhancing expression of the antiviral defence mRNAs in cellular conditions where cap-dependent translation is compromised.

Indexed as

Protein BiosynthesisA549 CellsApoptosis Regulatory ProteinsChemokine CCL5Chemokine CXCL10CytokinesDEAD Box Protein 58Gene Expression RegulationHeLa CellsHost-Pathogen InteractionsHumansInterferon-betaIntracellular Signaling Peptides and ProteinsNuclear Factor 90 ProteinsPoly I-CPolyribosomesApoptosis Regulatory ProteinsCCL5 protein, humanChemokine CCL5Chemokine CXCL10CXCL10 protein, humanCytokinesDEAD Box Protein 58IFIT2 protein, humanIFIT3 protein, humanILF3 protein, humanInterferon-betaIntracellular Signaling Peptides and ProteinsISG15 protein, humanNuclear Factor 90 ProteinsPoly I-CReceptors, ImmunologicRIGI protein, humanRNA-Binding ProteinsRNA, Double-StrandedRNA, MessengerRNA, ViralUbiquitins

Identifiers

PMID31701124
PMCPMC7145544
OpenAlexW2988341280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.